Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(2):143-144;
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Stefanek, M.
Right arrow Articles by Nelson, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Stefanek, M.
Right arrow Articles by Nelson, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 2, 143-144, January 16, 2002
© 2002 Oxford University Press

CORRESPONDENCE

RESPONSE: Re: Risk-Reduction Mastectomy: Clinical Issues and Research Needs

Michael Stefanek, Lynn Hartmann, Wendy Nelson

Affiliation of authors: M. Stefanek, W. Nelson, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; L. Hartmann, Division of Medical Oncology, Mayo Clinic, Rochester, MN.

Correspondence to: Michael Stefanek, Ph.D., National Institutes of Health, Rm. 4066, Executive Plaza North, MSC 7363, Bethesda, MD 20892 (e-mail: ms496r@nih.gov).

Dr. Swanson raises several important concerns about risk-reduction mastectomy (RRM) in response to our review (1). These include how best to communicate risk and benefit, avoid unnecessary procedures, and direct future research.

With respect to quantifying risk reduction, relative risk is the accepted standard for reporting in . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?